Intressa Vascular SA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Intressa Vascular SA - overview
Established
1998
Location
-, -, Belgium
Primary Industry
Medical Devices & Equipment
About
Based in Isnes, Belgium, and founded in 1998, Intressa Vascular SA, formerly known as Cardiatis SA, operates as a developer of a healthcare device, Allay™ Aortic Stent that treats patients' Type B aortic dissections. In October 2022, Intressa Vascular SA raised EUR 6 million in grant funding from The Walloon Region of Belgium. As of October 2022, the company has a team of 30 people and is led by its CEO Pierre Douette, and CSO Diane Lejeune. Intressa Vascular SA develops a proprietary braiding technology platform in combination with personalized procedure planning that allows the production of multilayer stents for the treatment of aortic dissection, a life-threatening cardiovascular condition.
Its device, the Allay™ Aortic Stent treats Type B aortic dissections (TBAD) and residual dissections designed to recentralize blood flow inside the true lumen, and reduce false lumen volume, while preserving branch perfusion. The company plans to use October 2022, funding to further develop its product offerings, expand on key markets, primarily the USA, Europe, and China and strengthen the organization's local foundation and growth.
Current Investors
Yonghua Capital, Noshaq, SRIW
Primary Industry
Medical Devices & Equipment
Sub Industries
Cardiology, Medical Equipment Distributors
Website
www.intressavascular.com
Verticals
Manufacturing
Company Stage
Late Stage
Total Amount Raised
Subscriber access only
Intressa Vascular SA - timeline of key events
Intressa Vascular SA - financials
| Fiscal Year Ended | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 3,149,950 | - | - | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | 1,463,378 | (117,440) | (11,455) | (2,975,634) | (3,135,435) | (1,446,808) | (1,762,578) | (2,875,519) | (793,006) | 4,933,714 | - | - | - |
| Operating Income (USD) | (1,018,911) | (2,911,280) | (3,082,147) | (6,482,898) | (6,986,125) | (5,812,391) | (5,745,295) | (5,988,198) | (3,231,886) | 3,740,725 | - | - | - |
| Operating Margin | (32.3%) | - | - | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | 46.5% | - | - | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | (886,515) | (2,996,359) | (3,221,274) | (6,619,421) | (7,093,397) | (5,821,835) | (6,174,372) | (6,946,912) | (4,071,147) | 3,769,851 | - | - | - |
| % Net Margin | (28.1%) | - | - | - | - | - | - | - | - | - | - | - | - |
Intressa Vascular SA - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.